Form 4: Procore Director Sells $1.1M in Stock Under 10b5-1 Plan

Procore Technologies Director Kevin J. O'Connor sold 15,384 shares of common stock for approximately $1.1 million through pre-arranged transactions.

Summary

• Kevin J. O'Connor, a Director of Procore Technologies, Inc. (PCOR), reported sales of common stock.
• A total of 15,384 shares were sold across four separate transactions on October 14 and October 15, 2025.
• The sales were executed at weighted average prices ranging from $70.25 to $72.91 per share.
• The total value of the shares sold amounts to approximately $1,100,620.14.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan established on November 21, 2024.
• Following these transactions, O'Connor beneficially owns 1,107,945 shares of common stock, held indirectly through the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine Form 4 filing reporting pre-scheduled insider stock sales under a 10b5-1 plan, which typically do not carry significant positive or negative implications for the company's fundamentals.

Negatives

• Director selling shares could be perceived negatively by some investors, potentially signaling a lack of confidence, although these sales were pre-scheduled under a 10b5-1 plan.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is specific to an individual insider transaction and does not provide broader industry context or trends. Insider sales, especially those under a 10b5-1 plan, are generally considered routine and not indicative of specific industry shifts.

Stakeholder Impact

• Shareholders may note the director's sale of shares, but the pre-arranged nature via a 10b5-1 plan generally mitigates concerns about immediate negative implications.

Key Dates

Recommendation

The filing reports routine insider stock sales executed under a pre-established 10b5-1 trading plan. Such planned sales are common for executives for personal financial planning and are generally not considered a strong indicator of future company performance or a reason to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as this specific filing does not provide new information warranting a change in investment strategy.

Keywords

PROCORE TECHNOLOGIES, PCOR, Insider Trading, Form 4, Stock Sale, Director, Kevin J. O'Connor, 10b5-1 Plan, Equity Transaction